GSK plc has received Orphan Drug Designation in Japan for its investigational antibody-drug conjugate risvutatug rezetecan (Ris-Rez) for the treatment of small-cell lung cancer, supported by early ...
A major UK clinical trial led by the University of Liverpool in collaboration with Cardiff University and NHS partners has demonstrated that a procalcitonin-guided diagnostic algorithm can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results